ANEC

Advanced Infusion Care (AIC) Now Offers Takeda’s GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] and ARALAST® NP [Alpha1-Proteinase Inhibitor (Human)]

Retrieved on: 
Monday, March 18, 2024

The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting.

Key Points: 
  • The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting.
  • “We’re excited and proud to be able to add Takeda’s Alpha1 therapies to our growing portfolio of infusion therapies,” said Jud Hall, President at AIC.
  • ARALAST NP increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1-PI.
  • AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.

Inhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency

Retrieved on: 
Tuesday, May 30, 2023

SAN DIEGO, May 30, 2023 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to INBRX-101, an optimized recombinant human AAT-Fc fusion protein, for the treatment of patients with emphysema due to alpha-1 antitrypsin deficiency (AATD).

Key Points: 
  • SAN DIEGO, May 30, 2023 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to INBRX-101, an optimized recombinant human AAT-Fc fusion protein, for the treatment of patients with emphysema due to alpha-1 antitrypsin deficiency (AATD).
  • Fast Track designation is granted by the FDA upon the request of the sponsor to facilitate the development and expedite the review of drugs intended to treat serious or life-threatening diseases.
  • Investigational drug products with Fast Track designation may benefit from early and frequent communication with the FDA, and are eligible for rolling submission and FDA review of its future marketing application.
  • The initial read-out from the ElevAATe trial is expected to occur in late 2024.

Grain Trade Re-Invented: global Agri-Tech provider Agro.Club enters Brazil

Retrieved on: 
Tuesday, August 2, 2022

NEW YORK, Aug. 2, 2022 /PRNewswire/ -- In line with its international expansion strategy, Agro.Club, a global AgTech solutions provider, announces its expansion into Brazil.

Key Points: 
  • NEW YORK, Aug. 2, 2022 /PRNewswire/ -- In line with its international expansion strategy, Agro.Club, a global AgTech solutions provider, announces its expansion into Brazil.
  • Its Full Stack B2B Grain Marketplace serves a vast unmet demand for grain trade digitalization, by making it more transparent, efficient, and risk-free for all players involved.
  • Brazil is the fourth largest food producer in the world with the Agricultural sector contributing approximately 5.9% of the country's GDP.
  • Brazil is one of the largest global producers of soybeans, corn, and sugarcane.

Soy produced in the State of Pará conforms to the social-environmental protocol

Retrieved on: 
Thursday, November 11, 2021

SÃO PAULO, Nov. 11, 2021 /PRNewswire/ -- The Pará State Federal Prosecutor's Office published the results of the Green Grain Protocol for crop years 2018/19 and 2019/20.  The numbers show that 96% of the soy produced in Pará, which occupies 30% of the Amazon Biome, conforms to strict social-environmental criteria.

Key Points: 
  • The numbers show that 96% of the soy produced in Par, which occupies 30% of the Amazon Biome, conforms to strict social-environmental criteria.
  • Nineteen of the Protocol's 35 signatory companies were audited.
  • They account for 90% of the state's soy, about 3.2 million tons.
  • "This is a positive example of how a public-private environmental governance initiative contributes efficiently to sustainability in production processes and, consequently, to Brazil's agribusiness image."

Recapture and ANEC Announce Carbon Removal Partnership

Retrieved on: 
Wednesday, September 22, 2021

"Here at ANEC, we feel really proud to collaborate and push forward brilliant innovations such as the one presented by our newest partner: Recapture.

Key Points: 
  • "Here at ANEC, we feel really proud to collaborate and push forward brilliant innovations such as the one presented by our newest partner: Recapture.
  • At Recapture, we designed a carbon capture project model that, instead of a massive annual sunk cost, makes it profitable to remove carbon and reach net zero emissions.
  • By providing carbon removal consultancy and training to organisations with ambitious climate goals, ANEC helps organisations achieve their net-zero targets.
  • The company develops systems-designed carbon removal projects for emitters that remove 10 times more carbon dioxide (CO) than natural solutions on their own.